Report - Mogamulizumab for PTCL - ER Congressi 29, 2015/03...Mogamulizumab is an effective agent with acceptable toxicities for relapsed PTCL & CTCL, leading to its approval in Japan in 2014.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form